ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,243, issued on May 13, was assigned to Cell Design Labs Inc. (Emeryville, Calif.).
"Methods and compositions for reducing the immunogenicity of chimeric notch receptors" was invented by Peter Emtage (Lafayette, Calif.), Amy E. Gilbert (San Francisco), Anselm Levskaya (Oakland, Calif.), Spencer Scott (San Francisco) and Vladimir Anatolievich Slepushkin (Vallejo, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods and compositions for reducing the immunogenicity of chimeric Notch receptors, and specifically to transcription factors useful for controlling gene expression delivered to tissues by such chimeric N...